Specific Biotechnologies
- Antibody-drug conjugate technologies
- Biomarker-driven therapies
- Biosimilars
- CAR-T cell therapy
- Checkpoint inhibitors
- Colony stimulating factors
- Digital inhalers
- Enzyme-replacement therapies
- Follow-on biologics
- Immune modulators
- Implantable contraceptive devices
- Monoclonal antibodies
- Respiratory delivery systems
- Sustained-release injectable prodrugs
- Targeted therapies
- Thermosensitive polymers
- Vaccine technology
- Viscosupplements and cartilage repair
Aventine has prepared dossiers and economic models for a wide variety of novel biotechnology products across many therapeutic areas. These products have included cutting-edge molecules and delivery systems in areas with substantial previously-unmet medical need. Our experience in biotechnologies is not limited to the list shown above; rather, the items listed illustrate the range of products for which we have provided writing services – encompassing recombinant technologies, novel drug-antibody conjugates, devices, and unique delivery systems.